TGase2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

TGase2 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
TGase2 shRNA Plasmid (h)

Product Specs
ItemTGase2 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-37514-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nametransglutaminase 2
NCBI Gene AliasesG(h), TG(C), TGC, hTG2, tTG
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoidCell death & diseaseJune 13, 2023Qin XY, Furutani Y, Yonezawa K, Shimizu N, Kato-Murayama M, Shirouzu M, Xu Y, Yamano Y, Wada A, Gailhouste L, et al.

(2) Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cellsDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapyMarch 1, 2023Li X, Ma Y, Wu J, Ni M, Chen A, Zhou Y, Dai W, Chen Z, Jiang R, Ling Y, et al.

(3) Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancerThe Journal of biological chemistryAugust 1, 2022Condello S, Prasad M, Atwani R, Matei D.

(4) Transglutaminase 2 mediates UVB-induced matrix metalloproteinase-1 expression by inhibiting nuclear p65 degradation in dermal fibroblastsExperimental dermatologyMay 1, 2022Lee SJ, Lee KB, Hong AY, Son YH, Lee DH, Jeong EM, Kim IG.

(5) Double-Stranded RNA Enhances Matrix Metalloproteinase-1 and -13 Expressions through TLR3-Dependent Activation of Transglutaminase 2 in Dermal FibroblastsInternational journal of molecular sciencesFebruary 28, 2022Hong AY, Lee SJ, Lee KB, Shin JW, Jeong EM, Kim IG.

(6) Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in DiabetesInternational journal of molecular sciencesJanuary 11, 2022Seo JA, Sayyed ND, Lee YJ, Jeon HY, Kim EB, Hong SH, Cho S, Kim M, Ha KS.

(7) Tissue Transglutaminase contributes to myelin phagocytosis in interleukin-4-treated human monocyte-derived macrophagesCytokineApril 1, 2020Sestito C, Brevé JJP, Bol JGJM, Wilhelmus MMM, Drukarch B, van Dam AM.

(8) The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunctionFASEB journal : official publication of the Federation of American Societies for Experimental BiologyNovember 1, 2019Lee JY, Lee YJ, Jeon HY, Han ET, Park WS, Hong SH, Kim YM, Ha KS.

(9) The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205American journal of cancer researchJanuary 1, 2019Seo S, Moon Y, Choi J, Yoon S, Jung KH, Cheon J, Kim W, Kim D, Lee CH, Kim SW, et al.

(10) Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formationOncotargetOctober 2, 2018Adhikary G, Grun D, Alexander HR, Friedberg JS, Xu W, Keillor JW, Kandasamy S, Eckert RL.

(11) Arachidonic acid suppresses hepatic cell growth through ROS-mediated activation of transglutaminaseFEBS open bioOctober 1, 2018Qin XY, Lu J, Cai M, Kojima S.

(12) Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinomaCell adhesion & migrationMarch 4, 2018Bagatur Y, Ilter Akulke AZ, Bihorac A, Erdem M, Telci D.

(13) Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem CellsAnticancer researchFebruary 1, 2018Kang S, Oh SC, Min BW, Lee DH.

(14) Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?Journal of neuroinflammationDecember 21, 2017Sestito C, Brevé JJP, van Eggermond MCJA, Killestein J, Teunissen CE, van Rossum J, Wilhelmus MMM, Drukarch B, van den Elsen PJ, van Dam AM.

(15) Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor FormationCancer researchDecember 15, 2016Fisher ML, Kerr C, Adhikary G, Grun D, Xu W, Keillor JW, Eckert RL.

(16) Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transitionOncotargetAugust 21, 2015Fisher ML, Adhikary G, Xu W, Kerr C, Keillor JW, Eckert RL.

(17) Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell SurvivalMolecular cancer research : MCRJuly 1, 2015Fisher ML, Keillor JW, Xu W, Eckert RL, Kerr C.

(18) Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathwaysInternational journal of cancerJune 15, 2014Kumar S, Donti TR, Agnihotri N, Mehta K.

(19) Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulationEur J CancerMay 1, 2013Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH.

(20) Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB PathwayBiomolecules & therapeuticsMay 1, 2012Lee HJ, Park MK, Bae HC, Yoon HJ, Kim SY, Lee CH.

Be the First to Write a Review!